Pascal and Francis Bibliographic Databases


Search results

Your search



A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 3195

  • Page / 128

Selection :

  • and

Persistence of central effects of pirlindole, a short-acting monoamineoxidase inhibitor, in the presence of a monoamineoxidase inhibitorSIMON, P; PONCELET, M; CHERMAT, R et al.Drug development research. 1985, Vol 5, Num 4, pp 323-326, issn 0272-4391Article

The lack of hepatotoxicity in the rat with the new and reversible MAO-A inhibitor moclobemide in contrasts to iproniazidSCHLAPPI, B.Arzneimittel-Forschung. 1985, Vol 35, Num 5, pp 800-803, issn 0004-4172Article

Monoamine Oxidase Inhibitors Revisited: What You Should KnowGOLDBERG, Joseph F; THASE, Michael E.The Journal of clinical psychiatry. 2013, Vol 74, Num 2, pp 189-191, issn 0160-6689, 3 p.Article

Advances Pertaining to the Pharmacology and Interactions of Irreversible Nonselective Monoamine Oxidase InhibitorsGILLMAN, Peter Kenneth.Journal of clinical psychopharmacology. 2011, Vol 31, Num 1, pp 66-74, issn 0271-0749, 9 p.Article

Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical useSIMPSON, G. M; FREDERICKSON, E; PALMER, R et al.Biological psychiatry (1969). 1985, Vol 20, Num 6, pp 684-687, issn 0006-3223Article

Aurorix : Generic name : MoclobemideSNAPE, M; MALLARKEY, G.Current therapeutics. 1996, Vol 37, Num 5, pp 87-88, issn 0311-905XArticle

Oxydation biomimétique de la pargylinePAUTET, F; BARRET, R; DAUDON, M et al.Pharmazie. 1986, Vol 41, Num 4, pp 286-287, issn 0031-7144Article

Interactions between relatively selective monoamine oxidase inhibitors and an inhibitors of 5-hydroxytryptamine re-uptake, clomipramineMARLEY, E; WOZNIAK, K. M.Journal of psychiatric research. 1985, Vol 19, Num 4, pp 597-608, issn 0022-3956Article

(Z)-2-(2,4-dichlorophenoxy)methyl-3-fluoroallylamine (MDL 72638): a clorgyline analogue with surprising selectivity for momoamine oxidase type BMCDONALD, I. A; PALFREYMNAN, M. G; ZREIKA, M et al.Biochemical pharmacology. 1986, Vol 35, Num 2, pp 349-351, issn 0006-2952Article

Médicament nouveau pour le praticien: Humoryl* = A new drug: Humoryl®La Revue du praticien (Paris). 1986, Vol 36, Num 36, pp 2135-2136, issn 0035-2640Article

Trials and tribulations with tribulinGLOVER, V.Biogenic amines. 1993, Vol 9, Num 5-6, pp 443-451, issn 0168-8561Article

Progress in the psychopharmacology of antidepressants: selective uptake and MAO-inhibitorsDELINI-STULA, A.Schweizer Archiv für Neurologie und Psychiatrie (1985). 1986, Vol 137, Num 5, pp 121-133, issn 0258-7661Article

Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. I: Inhibition by a selective monoamine oxidase-B inhibitor, MD 780236KINEMUCHI, H; MORIKAWA, F; UEDA, T et al.Japanese journal of pharmacology. 1986, Vol 41, Num 2, pp 183-189, issn 0021-5198Article

The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatmentBRADBURY, A. J; COSTALL, B; JENNER, P. G et al.Neuroscience letters. 1985, Vol 58, Num 2, pp 177-181, issn 0304-3940Article

Imbroglios autour de la M.A.O et des I.M.A.O = Problems about MAO and IMAOESCANDE, M.Journal de psychiatrie biologique et thérapeutique. 1987, Num 25, issn 0292-2509, 32Article

Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. II: Inhibition by α-methylated substrate-analogue monoamines, α-methyltryptamine, α-methylbenzylamine and two enantiomers of α-methylbenzylamineARAI, Y; TOYOSHIMA, Y; KINEMUCHI, H et al.Japanese journal of pharmacology. 1986, Vol 41, Num 2, pp 191-197, issn 0021-5198Article

A monoamine oxidase inhibitor reverses the separate syndromë in a new hamster separation model of depressionCRAWLEY, J. N.European journal of pharmacology. 1985, Vol 112, Num 1, pp 129-133, issn 0014-2999Article

The metabolic fate of pargyline in rat liver microsomesWELI, A. M; LINDEKE, B.Biochemical pharmacology. 1985, Vol 34, Num 11, pp 1993-1998, issn 0006-2952Article

New directions in monoamine oxidase A and B : selective inhibitors and substrates. CommentaryYOUDIM, M. B. H; FINBERG, J. P. M.Biochemical pharmacology. 1991, Vol 41, Num 2, pp 155-162, issn 0006-2952, 8 p.Article

«Spontaneous» hypertensive episodes with monoamine oxidase inhibitorsFALLON, B; FOOTE, B; WALSH, B. T et al.The Journal of clinical psychiatry. 1988, Vol 49, Num 4, pp 163-165, issn 0160-6689Article

Selegiline in narcolepsyROSELAAR, S. E; LANGDON, N; LOCK, C. B et al.Sleep (New York, NY). 1987, Vol 10, Num 5, pp 491-495, issn 0161-8105Article

Single dose of tranylcypromine increases human plasma melatoninOXENKRUG, G. F; MCINTYRE, I. M; BALON, R et al.Biological psychiatry (1969). 1986, Vol 21, Num 11, pp 1085-1089, issn 0006-3223Conference Paper

Monoamine oxidase inhibitors : new developments. SymposiumPAYKEL, Eugene S; YOUDIM, Moussa B. H.Clinical neuropharmacology. 1993, Vol 16, issn 0362-5664, SUP2Conference Proceedings

MoclobemideCurrent therapeutics. 1992, Vol 33, Num 5, pp 31-32, issn 0311-905XArticle

Proceedings/MAO-B-inhibitor selegiline (R-(―)-deprenyl), a new therapeutic concept in the treatment of Parkinson's disease, international symposium, Berlin, January 23-25, 1987RIEDERER, P; PRZUNTEK, H; FISCHER, P.-A et al.Journal of neural transmission. Supplementum. 1987, Num 25, issn 0303-6995, X-197 pConference Proceedings

  • Page / 128